Učitavanje...
Radiosensitization by the investigational NEDD8-activating enzyme inhibitor MLN4924 (pevonedistat) in hormone-resistant prostate cancer cells
Salvage radiotherapy (SRT) is the first-line treatment for prostate cancer patients with biochemical recurrence following radical prostatectomy, and new specific radiosensitizers are in urgent need to enhance SRT effect. MLN4924 (also known as Pevonedistat), a specific inhibitor of NEDD8-activating...
Spremljeno u:
Izdano u: | Oncotarget |
---|---|
Glavni autori: | , , , , , , , , , , , , , |
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
Impact Journals LLC
2016
|
Teme: | |
Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5122397/ https://ncbi.nlm.nih.gov/pubmed/27224919 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9526 |
Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|